Kazakhstan vs New Zealand: Hypertension: effective treatment coverage (controlled hypertension)
Kazakhstan
30.6%
in 2019
New Zealand
30.1%
in 2019
Kazakhstan rank
32nd
New Zealand rank
35th
Hypertension: effective treatment coverage (controlled hypertension) over time
- Kazakhstan
- New Zealand
How they compare
Kazakhstan currently reports 30.6% against 30.1% in New Zealand, a difference of 0.5%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was New Zealand ahead.
Kazakhstan ranks 32nd and New Zealand ranks 35th of 193 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 8.5% | 10.9% | 2.5% | New Zealand |
| 2000s | 15.6% | 21.7% | 6.0% | New Zealand |
| 2010s | 25.3% | 29.6% | 4.3% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), Kazakhstan or New Zealand?
- Kazakhstan, at 30.6% against 30.1% in New Zealand as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between Kazakhstan and New Zealand?
- 0.5%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and New Zealand?
- 30 years are reported by both, from 1990 to 2019.
- How do Kazakhstan and New Zealand rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- Kazakhstan ranks 32nd and New Zealand ranks 35th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.